The primary aim of this Clinical Scholarly Project was to assess the effectiveness of coaching sessions and a mobile reminder application to enhance medication adherence in adults at an outpatient psychiatric clinic. Several studies have suggested that patients with chronic health conditions adhere to 50-60% of the prescribed medication regimen. However, up to 80% of patients with psychiatric disorders fail to comply with their medication regimens. This translates into annual costs of $100-$300 billion per year for individual patients and healthcare systems, which significantly burdens the current healthcare system. A pre-and postquasi-experimental time series design was implemented for four months. The group of 15 participants was monitored for the first two months, using traditional care (e.g., presenting at the outpatient psychiatric clinic for evaluation, diagnosing, and medications management). After two months, the same group received the interventions: coaching sessions and a mobile reminder application. To determine whether the aims of the project were met, an independent paired t-test was performed to compare pre-and post-intervention data. Conclusion: A paired-samples t-test confirmed that the medication adherence rates differed between the two post-intervention months (Times 3 and 4), t (9) = 6.00, p< .01.
Introduction
The purpose of this research was to examine the effects of the use of coaching sessions and a mobile reminder application to enhance medication adherence in adults at an outpatient psychiatric clinic at Exodus Recovery, anoutpatient adult mental health clinic in downtown Los Angeles. Patients of this clinic frequently do not adhere to their prescribed medication regimen, which can lead to significant health consequences. This pattern is supported by studies that suggest approximately 125,000 deaths per year in the US are linked to medication nonadherence (Osterberg & Blaschke, 2005) . These statistics indicate that medication non-adherence has become a public health hazard.
Several studies (Chapman & Horne, 2013; Osterberg & Blaschke, 2005) have suggested that patients with chronic health conditions adhere to 50-60% of the prescribed medication regimen. However, up to 80% of patients with psychiatric disorders fail to comply with their medication regimen (Osterberg & Blaschke, 2005) . Osterberg & Blaschke note that this translates into annual costs of $100-$300 billion per year for individual patients and healthcare systems, which significantly burdens the current healthcare system. This figure includes costs for emergency-room visits, hospital readmissions, and reordering medications that were never filled or taken. Sometimes, providers are led to believe that a medication change is in order when in reality the patient never took the previous medication or even filled the prescription.
With approximately 3 billion prescriptions written per year in the US alone, the cost of medication has been increasing. It is further estimated that only 50-60% of such medication are consumed as prescribed (Varshney, 2013) .
Improving medication adherence is a continuous process. A poor match between patient readiness and any interventions can compromise medication adherence. A WHO (2003) study reported that electronic reminders play a supportive role in enhancing medication adherence and WHO has prioritized the use of new technologies to assist health delivery in underserved areas.
A systematic review of mobile phone messaging to improve adherence noted that mobile phone applications are worth exploring (Wise & Operario, 2008) . Mbuagbaw et al. (2011) found that mobile phone technology could help address medication non-adherence and open communication channels between patients and providers. Electronic reminders, which work by prompting the patient to self-administer their medication, come in many forms, including beepers, pagers, mobile phones, and pill box alarms.
A randomized clinical trial conducted by Wolever et al. (2010) evaluated the effectiveness of integrated health coaching on psychosocial factors, behavior change, and glycemic control. Fifty-six patients with type-2 diabetes were randomly assigned to a six-month coaching program. Statistical analysis was performed using the software package SPSS version 17 and independent sample t-tests. Medication adherence improved in the coaching group (Z = -2.862; p =.004). The study also indicated that single-based interventions were sufficient.
Cocosila, Archer, Haynes, and Yuang (2009) conducted a randomized control trial of 102 subjects. Subjects were randomized using a JavaScript program. A multivariate analysis of variance (MANOVA) omnibus test, an analysis of variance (ANOVA) analysis, and a two-tailed t-test revealed that adherence was increased (246% for the intervention group vs. 131% for the control group) by the use of wireless text messaging. The study revealed a significant correlation (coefficient=-0.352, sig.+0.01) between the average number of text messaging acknowledgements sent by the intervention group participants and the number of pills they reported missed during the last week of the trial Another randomized control trial was conducted by Shapiro et al. (2012) to evaluate whether daily text messaging was effective in enhancing weight-loss interventions in a randomly selected group of 117 obese subjects. Group differences in weight loss were tested using mixed models. An "intent to treat" (ITT) approach was utilized. Missing data were first input via multivariate imputation by chain equations (MICE). The results indicated that text messaging had a moderately strong effect (69% I vs. 60% C) on weight-loss interventions and could be a useful adjunct to weight-loss treatments.
A randomized controlled trial by Pop-Eleches et al. (2011) tested the efficacy of short message service (SMS) reminders to improve adherence to ART in 431 adult patients who had initiated ART within the previous three months.These patients were enrolled and randomly assigned to a control group or one of the four intervention groups.
Participants in each of the intervention groups received daily and/or weekly reminders. Adherence was measured using an electronic medication-monitoring system. Differences between the intervention groups and the control group were compared using Pearson's chi-squared test. Two level analyses were conducted: a summary analysis and a subgroup analysis. All analyses were conducted using the statistical software package STATA (version 10.0). The ITTanalysisresults showed that 53% of the participants who received weekly SMS reminders achieved adherence of at least 90% during the 48 weeks of the study, compared with 40% of the participants in the control group (P=0.03). Participants who received weekly reminders were also significantly less likely to experience treatment interruptions exceeding 48 hours during the 48-week follow-up period than participants in the control group (81 vs. 90%, P = 0.03).
The effectiveness of mobile technology-based behavior change or disease-management interventions for healthcare consumers was evaluated via a systematic review conducted by Free et al. (2013) . Search strategies identified 26,211 electronic records, which were screened for eligibility; 334 potentially eligible reports were obtained. Seventy-five trials were identified. Fifty-nine trials investigated the use of mobile technology and determined that textmessaging interventions increased adherence to ART. Sheppard et al. (2013) conducted a randomized control of women's non-adherence to mammograms, to study the effectiveness of brief telephone-coaching adherence interventions. Fifty-four women participated: 17 in the intervention group and 31 in the control group. A mixed-method descriptive design was used, interventionists were blinded, and descriptive statistics (including means and standard deviations) were used. After the intervention, most of the women who had missed appointments (94.5%) rescheduled them. More women in the intervention group kept their appointments (54%) than those in the usual care group (46%). Burda, Haack, Duarte, and Alemi (2012) conducted a study on the effectiveness of using mobile phones to communicate with homeless people. Ten homeless individuals were selected and provided with mobile phones. The phones were programmed into an automated telephone system for 30 days. Participant responses were reported to a computer. Participants were administered MINI, CES-D and ASI-Lite before the phone protocol was initiated, electronic surveys were administered daily, and Voxio's interactive response system was used. Data was analyzed using probability charts, reporting the percentage of patients who responded. The intervention reached 90% of the participants, confirming that mobile phones were a valuable and effective method of reaching homeless patients. Vervloet et al. (2012) conducted a randomized controlled trial to assess the effectiveness of interventions that used electronic reminders to improve adherence to chronic medication. Data was collected for 104 type-2 diabetes patients with suboptimal adherence to oral anti-diabetics. Fifty-six patients were randomized to receive SMS reminders to take their medication, while 48 patients received no reminders. The results indicated that patients who received SMS reminders took significantly more doses within a predefined time window (one hour) than patients who received no reminders:50% vs. 39%(p = 0.03). Reminded patients tended to missed doses less frequently than patients who were not reminded (15% vs. 19%, p = 0.065). Velligan et al. (2013) conducted a randomized controlled study that compared the effectiveness of in-person and electronic reminders for improving adherence to oral medication in patients with schizophrenia. Repeated measured ANOVA for mixed models indicated that adherence to medication was significantly better in both active conditions than in the "treatment as usual"(TAU) group (both p<0.0001). In active treatments, adherence ranged from 90% to 92%, compared to 73% in treatments based on electronic monitoring.
Interian, Fernandez-Lewis, Gara, and Escobar (2013) used a randomized controlled trialto examine the efficacy of motivational interviewing for improving antidepressant adherence among Latinos with a depressive disorder. Participants were randomized to receive usual care (UC) or Motivational Enhancement Therapy for Antidepressants (META). After adjusting for covariates, the META participants showed significantly higher antidepressant adherence than the UC participants (72% vs. 42%, respectively, p<0.01).
Theoretical Framework
The Health Belief Model (HBM) was used as the theoretical framework for this study's implementation of the mobile reminder application project at an adult outpatient psychiatric clinic. The HBM was developed in the early 1950s by a group of psychologists at the US Public Health Service, in an attempt to understand the failure of the public to accept preventive measures and/or early tests for detection of asymptomatic disease (Janz & Becker, 1984) . The HBM is a value-expectancy theory that considers the value an individual places on maintaining their well-being or seeking out treatment. HBM emphasizes that an individual's beliefs are a predictor of the likelihood that they will take action. The notion of value-expectancy is derived from cognitive theorists such as Kurt Lewin (Gipson & King, 2012) .
The HBM theorizes that health-related actions depend on the following factors (Janz & Becker, 1984 ):
1. Perceived susceptibility: There must be sufficient motivation or concern about health to make the health issues relevant. For example, a patient diagnosed with depression must believe in the diagnosis, their susceptibility to the illness, and that the illness may be contracted. 2. Perceived severity: This is the belief that one is vulnerable to the sequelae of the condition suffered. There must be a perceived threat. Patients must feel that if their condition is left untreated, they risk disability, pain, social consequences, and/or death. 3. Perceived benefits: This is the belief that following a particular recommendation or action plan would be advantageous, and that the barriers and costs can be overcome. In the proposed project coaching sessions, pharmaco-education and use of the mobile reminder application are recommended actions that may reduce the disease threat. 4. Perceived barriers: The patient must weigh the proposed action's effectiveness against the perception that the medication and/or interventions may be dangerous (e.g., side effects), unpleasant, painful and/or time consuming.
Study Design and Methodology

Project Design
A pre-and post-quasi-experimental time series design was implemented for four months. The group of 15 participants was monitored for the first two months using traditional care (e.g., presenting at the outpatient psychiatric clinic for evaluation, diagnosing, and medications management). After two months, the same group received the intervention's coaching sessions and a mobile reminder application. Adherence percentage rates were collected at the end of the first, second, third, and fourth month. To determine whether the aims of the project were met, a paired samples t-test was performed to compare pre and post data.
Setting and Sample
Study participants were selected from an adult outpatient psychiatric medication clinic located in East Los Angeles, California. Inclusion criteria were as follows: both genders, all ethnicities, aged 18 or older, Axis I Diagnosis of Depression, and patients who had missed two consecutive medication follow-up appointments, possessed an IPhone or Android phone, lived in a home/apartment, and who were full-time residents of Los Angeles, California. Exclusion criteria were as follows: agedless than 18 years, Dual Diagnosis, Axis I other than that stated in the inclusion criteria, and patients who had no cell phone and were homeless.
Procedures
Fifteen adults aged 18-65 were randomly selected from the Affinity Information System (AIS). The list of participants was not in any alphabetical order. Recruitment took place by contacting participants by personal phone, followed by a face-to-face confidential screening for each participant.The researcher followed the Initial Patient Questionnaire (see Appendix F) to ensure consistency of information discussed with each participant. Informed consent was obtained, with full disclosure of the research expectations of participants. Participants were able to opt out at any time during the study. A unique identifier number was used to protect patient information, with any information collected put into a data source that was coded with a numbering system. Study data were kept in a locked file located in the clinic's medical records unit.
The researcher screened the charts for pre-implementation data, using a retrospective review of mental health charts for age, gender, psychiatric diagnosis, current diagnosis, and current compliance rate. Compliance with the US Department of Health and Human Services 45 C.F.R. 164.316 was followed for accessing records and for documentation and reporting purposes. A convenience sample of 15 patients was obtained from the preimplementation data of patients who had missed two or more appointments. The potential non-adherent patients were monitored for the first and second month. A monthly pill count was conducted on the first and second month, utilizing the medication possession ratio (MPR).This is a calculation that is commonly used in health research and is supported by the International Society for Pharmaceutical and Outcomes Research (Fortney, Pyne, Edlund, & Mittal, 2010; Hoch & Dewa, 2008; Rolnick, Pawloski, Brita, Asche, & Bruzek,2013) . As recommended by Kozma, Dickson, Phillips, and Meletiche (2013) , medication adherence for this study was calculated by dividing the total number of days the patient was on a medication and the number of days the patient reported taking the medication or a monthly pill count.
The 15 patients in this study who were identified as having poor medication adherence were given monthly coaching sessions (see Appendix G), of 10 minutes' duration, at the beginning of the third and fourth month and provided with instructions on how to use the mobile reminder application, Dosecast (see Appendix H). The coaching sessions centered in a process to discuss factors associated with medication non-adherence,to facilitate healthy, sustainable behavior change by challenging a client to listen to their inner wisdom, identify their values, and transform their goals into action.
The researcher entered all medication information (name of medication, dose, and frequency) into Dosecast. At the end of the fourth month, the participants emailed the mobile reminder application data to the researcher. The mobile reminder application data were downloaded and the adherence rates were obtained utilizing the MPR. All data were recorded on a locally developed data collection tool (see Appendix E) and the information was then entered into SPSS Statistics Grad Pack 22.0 program for statistical data analysis. Dosecast was selected as the mobile application for this study because of the expectation that it would enhance medication adherence. According to the software, it is "a flexible, easy-to-use medication management application that is available free of charge for Apple, Android, and Amazon devices" (Arya, 2014) . Dosecast offered the following features (Arya, 2014) :
Reliably sent dose reminders whether or not the subject had an internet connection. Tracked the subject's time zone and adjusted reminders accordingly. Enabled doses to be skipped before or after their scheduled time. Displayed the drug name, dosage information, and directions in the reminders for each dose.
Post-implementation data collection on compliance outcomes was undertaken at the end of the fourth month, to determine whether the aims of the project had been met. To assess this, a paired samplest-test was performed, comparing baseline compliance data with data collected after the program implementation.
Protection of Human Subjects
The captured data was stored according to Human Subject Protection laws with a copy stored in a doubledlocked site with keys heldonly by the principal investigator.
Data Analysis
Patient medication adherence data were collected at 30 and 60 days (called Times 1 and 2)before the coaching sessions and the use of the mobile reminder application. The group was thengiven monthly coaching sessions and the use of the mobile reminder application for a period of 60 days. Medication adherence data was obtained again during the 3rd and 4th month of the study, after the coaching sessions and the use of the mobile reminder application (called Times 3 and 4). Medical adherence was calculated based on the number of days a patient received a given medication vs. the number of days the patient reported taking the medication.
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International Journal of Nursing, Vol. 2(2), December 2015 First, descriptive statistics were calculated to understand the demographic characteristics of the sample. Next, pre-adherence rates were examined to test if rates differed in the two months prior to the intervention, using a pairedsamples t-test. Demographic characteristics were examined at all of the time points to see if there were any demographic differences in adherence rates prior to the intervention. If the demographic data was continuous (e.g., education and age) then correlations were conducted. If the demographic data was categorical (e.g., race and gender) one-way ANOVAs were conducted. Post-adherence rates were then compared to see if the rates for the two months after intervention were different, using a paired-samples t-test. Finally, to test the hypothesis of whether the intervention increased adherence rates, paired-samples t-tests were conducted comparing pre-and post-intervention adherence.
The results of the t-test comparing Times 3 and 4 were significant, indicating that it is not possible to combine or average the post-intervention data together (i.e., each post-intervention month has to be compared separately with the pre-intervention data). Therefore, four separate paired-samples t-tests were conducted to test the research hypothesis, as follows: 
Results
Description of Sample
A total of 15 participants took part in the study. Gender was almost evenly split in the sample, with eight males and seven females. Ethnicity was also fairly balanced, withfour Caucasian participants, 6 Hispanic/Latino participants, and five African American participants. The education level of the sample was low: 73% of the sample had never earned a high school degree; two participants (13.3%) graduated from high school;one participant earned an Associate's Degree; and one participant earned a Bachelor's Degree. The ages ranged from 22 to 66 years, with the average age being 44.53 (SD = 14.58). See Table 1 for demographic characteristics of the sample.
Medication Adherence
At Time 1 (before any intervention) the average medication adherence rate of the 15 participants was 53.10% (see Figure 1) , with adherence rates ranging from 30.00% to 73.33%. One participant did not provide any medical adherence data at Time 1 and was dropped from all further analyses. At Time 1, females had better adherence to their medication regimen (M = 62.22%, SD = 10.03%) than males (M = 46.25%, SD = 11.05%). The difference between male and female adherence at Time 1 was tested using an independent-samples t-test and was found to be significant, t(12) = 2.78, p = .02 (see Figure 2) . As participants' age was not correlated to adherence rates at Time 1 (r = -.04, p = .88) it was clear that adherence rates did not differ by the participant's age. Education was also not related to adherence rates at Time 1 (r = -.26 p = .37), and nor was ethnicity (Caucasian M = 44.44%, SD = 7.62%; Hispanic/Latino M = 53.89%, SD = 5.39%; African American M = 57.33%, SD = 5.90%, p = .43-see Figure 3 ). At Time 2 (one month after Time 1, but still with no interventions), the average adherence rate was 51.02%, with rates ranging from 33.33% to 70.00% (see Figure 1) . One participant's data was not available at Time 2. A paired-samples t-test confirmed that adherence rates did not differ between the two pre-intervention months (Times 1 and 2), t(12) = 1.33, p = .208. At Time 2, females still had better adherence to their medication regimen (M = 60.00%, SD = 10.32%) than males (M = 43.33%, SD = 8.16%) (see Figure 2) . The difference between male and female adherence rates at Time 2 was tested and was found to be significant, t(11) = 3.25, p< .05. As participants' age was not correlated to adherence rates at Time 2 (r= -.22, p = .46), it was clear that adherence rates did not differ by the participant's age. Education was also not related to adherence rates at Time 2 (r = -.21 p = .50) and nor was ethnicity (Caucasian M = 43.33%, SD = 7.21%; Hispanic/Latino M = 51.33%, SD = 5.58%; African American M = 55.33%, SD = 5.58%, p = .44-see Figure 3 ).
Time 3 was the first post-intervention month. The average adherence rate for the sample was 58.88%, with adherence rates ranging from 36.67% to 76.67%. Two participants' data were not available at Time 3 (see Figure 1) . At Time 3, females still had better adherence to their medication regimen (M = 68.33%, SD = 8.26%) than males (M = 49.45%, SD = 9.28%) (see Figure 2) . The difference between male and female adherence at Time 3 was tested and was found to be significant, t(10) = 3.70, p< .01.
As participants' age was not correlated to adherence rates at Time 3 (r= -.08, p = .82), it was clear that adherence rates did not differ by the participants' age. Education was also not related to adherence rates at Time 3 (r = -.21 p = .50) and nor was ethnicity (Caucasian M = 53.33%, SD = 9.77%; Hispanic/Latino M = 57.33%, SD = 6.16%; African American M = 62.66%, SD = 6.16%, p = .69-see Figure 3 ). Two months after the intervention (Time 4), the average adherence rate was 72.66%, with adherence rates ranging from 63.33% to 83.33%. Four participants' data was not available at Time 4 (see Figure 1) . At Time 4, females had better adherenceto their medication regimen (M = 77.33%, SD = 7.22%) than males (M = 67.99%, SD = 5.05%), t(8) = 2.36, p = .045 (see Figure 2) . As participants' age was not related to adherence rates at Time 4 (r = -.24, p = .50), it was clear that post-intervention adherence rates did not differ by the participants' age. Education was also not related to adherence rates at Time 4 (r = .04 p = .91) and nor was ethnicity (Caucasian M = 70.00%, SD = 4.71%; Hispanic/Latino M = 74.99%, SD = 8.81%; African American M = 7166%, SD = 8.81%, p = .76-see Figure 3) . A paired-samples t-test confirmed that adherence rates did differ between the two post-intervention months (Times 3 and 4), t(9) = 6.00, p< .01. Adherence rates at Time 4 (two months post-intervention) were significantly higher than adherence rates at Time 3 (one month post-intervention).
Testing the Success of the Intervention
Paired-samples t-tests were conductedto test the success of the intervention (the main analysis to test the research hypothesis). Pre-intervention adherence rates at Times 1 and 2 were compared with the post-intervention adherence rates at Time 3 and 4. Paired-samples t-tests were conducted to see if adherence rates significantly increased between pairs of time before and after the intervention, as follows:
Adherence rates at Time 3 (58.89%) were significantly higher than adherence rates at Time 1 (53.33%). The paired-samples t-test confirmed this, t(11) = 5.38, p < .01.
Adherence rates at Time 3 (58.89%) were significantly higher than adherence rates at Time 2 (51.67%). The paired-samples t-test confirmed this, t(11) = 8.99, p < .01.
Adherence rates at Time 4 (72.67%) were significantly higher than adherence rates at Time 1. The pairedsamples t-test confirmed this, t(9) = 10.37, p < .01.
Adherence rates at Time 4 (72.67%) were significantly higher than adherence rates at Time 2. The pairedsamples t-test confirmed this, t(9) = 9.47, p < .01.
Thus, it can be concluded that the intervention successfully increased adherence rates. Race, gender, and educational level have been studied in the US as factors in non-adherence to medication. Some studies have indicated that Caucasians are believed to have good compliance (Jin, Grant, Vernon, & Shu, 2008) . Studies by Rahul, Balkrishnan, Camacho, Whitmire; Roger (2006) and Adams et al. (2008) revealed that African Americans' adherence to a medication regimen is lower than that of Caucasians whites.A study conducted by Shiah et al. (2014) revealed that male patients adhere more effectively to a medication regimen than females patients do. Manteuffel, William, Verbrugge, Pittman, and Steinkellner (2014) also found that women are less likely than men to have good adherence in their use of chronic medication and are less likely to receive the medication treatment and recommended monitoring. Although no studies could be found regarding a link between education level and adhering to a medication regimen, a study by Alkatheri and Albekairy (2013) found that a higher educational level positively affectslevel of medication knowledge.
. Conversely, this current study found that females had better adherence to their medication regimen (M = 77.33%, SD = 7.22%) than males (M = 67.99%, SD = 5.05%, t(8) = 2.36, p = .045). There were also no differences in adherence rates at Time 4 by ethnicity: Caucasian (M = 70.00%, SD = 4.71%), Hispanic/Latino (M = 74.99%, SD = 8.81%), African American (M = 7166%, SD = 8.81%), p = .76 (see Figure 3) . Additionally, education level was not related to adherence rates at Time 4, r = .04 p = .91.
The overall goal of this study, whichis believed to be the first to investigate this topic, was to address nonadherence to medication regimens in an adult psychiatric outpatient clinic by implementing monthly coaching sessions coupled with the use of a mobile reminder application. A number of small studies have previously documented increased medication adherence through the use of SMS, telephone call reminders, and educational and motivational interviewing. The findings of this current study have supported those results, and suggest that coaching sessions and the use of a mobile reminder application can significantly improve medication adherence.
These results are promising because increased medication adherence is associated with better health outcomes, including reduced relapses and fewer hospitalizations (Braithwaite, Shirkhorshidian, Jone, & Johnsrud, 2013) . 
Application to Practice
The evidence strongly suggests that patients' medication adherence rates improve with the use of mobile reminder applications. As noted by former Surgeon General C. Everett Koop (Institute for Nurse Practitioner Excellence, n.d.), "… drugs don't work in patients who don't take them." Providers must remain cognizant that medication non-adherence contributes to suboptimal clinical benefits. Poor medication adherence translates into increased use of healthcare, such as hospitalizations, which are more costly and time consuming than medications management (Braithwaite et al., 2013) . That is, when patients do not adhere to medication regimen they require more expensive services. In fact, medication non-adherence is involved in more than one-third of medication-related hospitalizations (Braithwaite et al., 2013) . The raw data regarding medication non-adherence at Exodus Recovery's adult outpatient clinic was approximately 62%. The literature suggests that utilizing text message reminders alone could improve medication adherence by 8-90% (Burda et al., 2012; Cocosila et al., 2009; Sheppard et al., 2013) . This current project utilized two interventions to reduce medication non-adherence rates: a mobile reminder application and coaching sessions.As anticipated, medication adherence rates increased. Implementing this medication adherence program would allow for a collaborative change in practice standards to increase the quality of care that Exodus Recovery providers can deliver to patients. Also, by reducing the economic burden of emergency-room and acute hospital stays, along with the co-morbidities of poorly controlled depression, a higher quality of life may be realized for patients.
Research suggests that patients who have an understanding of medication adherence and non-adherence realize that their behaviors can directly affect their treatment and quality of life; however, more research is needed to address critical issues in this area (DiMatteo et al., 2002; Sheppard et al., 2013; Wolever et al., 2010) . Future studies regarding medication adherence should use other methods to help identify the specific non-adherence issues involved (e.g., primary non-adherence, execution of medication regimen, lack of patient education, and socioeconomic factors) because each of these may require a different intervention. Additional research is required to increase understanding of the relationships between adherence, outcomes, and healthcare costs.
Lack of medication adherence is a well-known and well-documented problem. The National Council on Patient Information and Education (NCPIE, 2007) notes that poor medication adherence has been a problem for many decades but has received few systemic interventions. Medication non-adherence is a crisis in the US and worldwide, and requires a coordinated approach to find solutions.To suggest that medication adherence is the fault of the patient is uninformed, counter-productive, and a perspective best abandoned. Implementing improvements in economic and health outcomes is a serious challenge for the health industry. In light of the Affordable Care Act, requiring policymakers to find new methods of improving healthcare outcomes. Mechanisms to encourage patients to adhere to medication regimens are now a national focus (Castellano, Copeland-Halperin, & Fuster, 2013) .
Limitations
The initial time involved in coaching the client and setting up the mobile reminder application may discourage some providers. Further, patients must possess an iPhone and/or an Android phone, potentially limiting the number of patients able to be included. This project focused only on Axis I Diagnoses of Depression and did not include children or the homeless. Depending on the outcomes of further studies, recommendations could be made to insurance companies to provide incentives to both providers and patients in the form of adherence tools and educational coaching sessions that improve medication adherence. These incentives could include reduced co-pay rates for patients with good adherence to their medicine regimensand free mobile phone applications to remind patients to take their medications as prescribed.
Summary
The objective of this study was to determine whether the medication adherence rates of patients at the Exodus Recovery clinic improved after the implementation of a mobile reminder application accompanied by scheduled coaching sessions. The study included an analysis of pre-and post-adherence rates.The study's results were clinically significant, showing an increased medication adherence rate. The study also had limitations of sample size and study time.
Therefore, a study that utilizes better study methods, and has more participants over a longer period, may show significant, measurable differences. Once interventions can be tailored to meet a patient needs, rather than offering the same intervention to all patients, better health outcomes will be possible.
Conclusions
Previous research has found that patients who have an understanding of medication adherence and nonadherence realize that their behaviors can directly affect their treatment and quality of life as it relates to their illness. However, further research is required to increase understanding of the association between adherence, outcomes, and healthcare costs.
Although adherence interventions appear to have improved medication adherence ratesin studies that included two or more interventions with patient-targeted changes, knowledge gaps remain. Medication adherence consists of a combination of a patient-provider relationship, socioeconomic factors, and education. Healthcare decision makers should avoid taking anà la carte approach to medication non-adherence.
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